All Practice Exams

Free Practice Questions for Egyptian Board Neurology

Exam-style questions and explanations by OpenExamPrep.

✓ No registration✓ No credit card
100+ Questions
100% Free

Loading practice questions...

Exam Review

Key Facts: Egyptian Board Neurology Exam

5 Years

Residency Program Duration

3 Parts

Examination Stages

Angoff / Hofstee

Standard-Setting Method

EHC

Examining Authority

The Egyptian Board in Clinical Neurology certification is governed by the Egyptian Health Council (EHC) under Law No. 12 of 2022 and Decree No. 3798 of 2023 across a 5-year residency program. The certification framework incorporates Part 1 (basic neurosciences: neuroanatomy, neurophysiology, neuropathology, neuropharmacology), Part 2 (written clinical neurology MCQs: vascular, epilepsy, demyelinating, movement, neuromuscular, cognitive, and infective disorders), and Part 3 (clinical OSCE and oral case stations). Minimum passing standards are established through Modified Angoff and Hofstee standard-setting (with Borderline Regression for Part 3) rather than fixed percentage cuts. Important notice: Part Three is an in-person clinical OSCE with practical examination stations; this 100-question practice bank is an independent English-language MCQ study aid targeting lesion localization, diagnostic criteria, neuro-electrophysiology, and clinical pharmacotherapy for Parts 1 and 2.

Sample Egyptian Board Neurology Practice Questions

Try these sample questions to review concepts for the Egyptian Board Neurology exam. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 58-year-old hypertensive male presents with acute-onset vertigo, intractable hiccups, hoarseness, dysphagia, and right-sided facial numbness. Neurological examination reveals right-sided Horner syndrome, right limb ataxia, and reduced pinprick sensation over the left arm, trunk, and leg. Which vascular territory is most likely occluded?
A.Right posterior inferior cerebellar artery (PICA)
B.Right anterior inferior cerebellar artery (AICA)
C.Right paramedian branch of the basilar artery
D.Right superior cerebellar artery (SCA)
Explanation: The patient presents with lateral medullary syndrome (Wallenberg syndrome), classically caused by atherothrombotic occlusion of the vertebral artery or the posterior inferior cerebellar artery (PICA). Ischemia involves the nucleus ambiguus (hoarseness, dysphagia, hiccups), vestibular nuclei (vertigo, nystagmus), descending sympathetic tract (ipsilateral Horner syndrome), inferior cerebellar peduncle (ipsilateral hemiataxia), spinal trigeminal nucleus (ipsilateral facial analgesia), and lateral spinothalamic tract (contralateral body analgesia).
2A 64-year-old female presents with sudden diplopia and left-sided weakness. Examination demonstrates a dilated, unreactive right pupil with right ptosis, inability to adduct or elevate the right eye, and a spastic hemiparesis involving the left face, arm, and leg. Which brainstem stroke syndrome best fits these findings?
A.Benedikt syndrome involving the midbrain tegmentum
B.Weber syndrome involving the ventral midbrain
C.Claude syndrome involving the dorsal midbrain
D.Nothnagel syndrome involving the superior colliculus
Explanation: Weber syndrome is a ventral (paramedian) midbrain syndrome resulting from occlusion of penetrating branches of the posterior cerebral artery or basilar bifurcation. It damages the exiting fascicles of the oculomotor nerve (ipsilateral complete third cranial nerve palsy with pupil dilation) and the descending cerebral peduncle/corticospinal tract (contralateral hemiparesis).
3A 61-year-old male with diabetes presents with acute diplopia and facial asymmetry. Physical examination reveals an inability to abduct the left eye, complete left-sided lower motor neuron facial weakness involving both the upper and lower face, and hyperreflexic hemiparesis of the right upper and lower extremities. Sensation is intact. What is the clinical diagnosis?
A.Foville syndrome of the dorsal pontine tegmentum
B.Raymond syndrome of the ventral mid-pons
C.Millard-Gubler syndrome of the ventral caudal pons
D.Babinski-Nageotte syndrome of the lateral medulla
Explanation: Millard-Gubler syndrome (ventral pontine syndrome) is caused by infarction of the ventral caudal pons in the territory of paramedian and short circumferential branches of the basilar artery. The lesion damages the exiting sixth nerve fascicles (ipsilateral lateral rectus palsy), exiting seventh nerve fascicles (ipsilateral peripheral facial palsy), and the uncrossed corticospinal tract (contralateral hemiparesis).
4A 70-year-old woman develops acute horizontal diplopia. Examination reveals that when looking to the right, neither eye moves past the midline conjugate to the right; leftward conjugate gaze is preserved. She also has right peripheral facial paralysis, right-sided sensorineural deafness, and left-sided hemiplegia. Conjugate horizontal gaze palsy distinguishes this presentation as which brainstem syndrome?
A.Marie-Foix syndrome
B.Gasperini syndrome
C.Raymond-Cestan syndrome
D.Foville syndrome
Explanation: Foville syndrome is a dorsal pontine tegmental syndrome typically caused by occlusion of circumferential basilar artery branches. Involvement of the paramedian pontine reticular formation (PPRF) or the abducens nucleus causes an ipsilateral horizontal conjugate gaze palsy, whereas involvement of the seventh nerve nucleus/fascicle produces ipsilateral peripheral facial palsy, and damage to the corticospinal tract produces contralateral hemiplegia.
5A 28-year-old male sustains a knife stab wound to the posterior thoracic spine. Neurological examination reveals right lower extremity spastic weakness (grade 3/5) with a positive right Babinski sign, loss of vibration and joint position sense below the right costal margin (T8 level), and loss of pain and temperature sensation below the left umbilicus (T10 level). Proprioception is normal in the left lower limb. Which spinal cord syndrome is present?
A.Brown-Séquard syndrome (spinal cord hemisection)
B.Anterior spinal cord syndrome
C.Central cord syndrome
D.Posterior cord syndrome
Explanation: Brown-Séquard syndrome is caused by functional or anatomical hemisection of the spinal cord. It causes ipsilateral upper motor neuron weakness (lateral corticospinal tract) and ipsilateral loss of vibration/proprioception (dorsal column), coupled with contralateral loss of pain and temperature sensation (lateral spinothalamic tract) beginning 1 to 2 segments below the lesion level due to the oblique crossing of second-order spinothalamic fibers in the anterior white commissure.
6A 67-year-old male develops sudden paraplegia, bilateral loss of pinprick and thermal sensation below the T6 dermatome, and acute urinary retention following thoracoabdominal aortic aneurysm repair. Joint position sense, light touch, and vibratory sensation in both lower extremities remain completely normal. Which vascular territory is compromised?
A.Artery of Adamkiewicz supplying the posterior spinal arteries
B.Anterior spinal artery territory in the midthoracic cord
C.Paired posterior spinal arteries at the thoracic level
D.Radiculomedullary veins with acute venous engorgement
Explanation: Anterior spinal artery (ASA) syndrome (Beck syndrome) results from infarction of the anterior two-thirds of the spinal cord, commonly seen after aortic cross-clamping affecting the great radicular artery of Adamkiewicz. The territory includes the anterior horns, lateral corticospinal tracts, and spinothalamic tracts, yielding bilateral paraplegia, sphincter failure, and dissociated sensory loss (loss of pain/temperature with complete sparing of dorsal column vibratory and proprioceptive senses).
7A 52-year-old female with long-standing Crohn disease presents with progressive sensory ataxia, paresthesias in a stocking-glove distribution, and leg stiffness. Examination reveals bilateral Babinski signs, hyperactive knee jerks, absent ankle jerks, and severe loss of vibratory and joint position sense in both lower limbs. Sensation to pinprick is preserved. What is the underlying spinal pathology?
A.Tabes dorsalis causing selective dorsal root gangliopathy
B.Amyotrophic lateral sclerosis with anterior horn cell loss
C.Subacute combined degeneration of the spinal cord
D.Adrenomyeloneuropathy causing isolated posterior column myelopathy
Explanation: Subacute combined degeneration (SCD) of the cord is caused by vitamin B12 (cobalamin) deficiency. It pathologically targets both the dorsal columns (producing profound loss of vibration, proprioception, and sensory ataxia) and the lateral corticospinal tracts (producing spasticity, hyperreflexia, and extensor plantar responses), often coexisting with a peripheral neuropathy that diminishes ankle reflexes.
8A 72-year-old male with severe cervical spondylosis is brought to the emergency department following a minor motor vehicle collision involving a hyperextension neck injury. Neurological examination reveals marked bilateral flaccid weakness of the hands and forearms (grade 2/5) with mild spastic weakness of the legs (grade 4/5). Sensory examination demonstrates loss of pain and temperature over the shoulders and arms, but intact sensation over the trunk, legs, and perianal region. What is the most likely diagnosis?
A.Acute anterior spinal artery occlusion
B.Complete transverse myelopathy
C.Conus medullaris syndrome
D.Central cord syndrome
Explanation: Central cord syndrome is the most common incomplete spinal cord injury, typically occurring in elderly patients with preexisting cervical spondylosis following hyperextension trauma. Because the cervical corticospinal fibers are organized more medially within the lateral corticospinal tract and the anterior horn cells at that level are injured, upper extremity motor deficit is disproportionately greater than lower extremity impairment, accompanied by a 'suspended' cape-like pain and temperature sensory loss with sacral sparing.
9A 45-year-old patient presents with acute bilateral leg weakness and urinary incontinence. Neurological evaluation reveals symmetric mild distal leg weakness, preserved knee reflexes, absent ankle reflexes, bilateral extensor plantar responses, early severe urinary and fecal incontinence, and dense numbness confined to the perianal and perineal areas (S3-S5). Which anatomical site is the lesion located?
A.Conus medullaris
B.Cauda equina
C.Thoracic spinal cord (T10)
D.High cervical cord (C2)
Explanation: Conus medullaris syndrome is characterized by acute, symmetric presentation, early and prominent sphincter dysfunction (overflow incontinence, fecal incontinence), perianal saddle anesthesia (S3-S5), and a mix of upper motor neuron signs (Babinski sign) and lower motor neuron signs (absent ankle jerks with preserved knee jerks).
10A 55-year-old female presents with severe right-sided retro-orbital pain and binocular diplopia. Examination reveals right eye ptosis, a fixed and dilated right pupil that does not react to direct or consensual light, and complete limitation of right eye adduction, elevation, and depression. What is the most critical immediate diagnostic consideration?
A.Microvascular ischemic oculomotor neuropathy
B.Posterior communicating artery (PComA) aneurysm
C.Tolosa-Hunt syndrome of the superior orbital fissure
D.Myasthenia gravis exacerbation
Explanation: A complete or partial third nerve palsy involving the pupil (mydriasis, loss of pupillary light reflex) is a neurosurgical emergency until proven otherwise, classically caused by external compression from an expanding posterior communicating artery (PComA) aneurysm. Parasympathetic pupilloconstrictor fibers travel along the superficial, dorsomedial periphery of the oculomotor nerve, making them highly vulnerable to ab externo aneurysmal compression.

About the Egyptian Board Neurology Exam

The Egyptian Board in Clinical Neurology is the official postgraduate specialty board certification administered by the Egyptian Health Council (EHC) under Law No. 12 of 2022 and Decree No. 3798 of 2023. Spanning a 5-year residency program, it assesses candidate mastery through Part 1 basic neurosciences, Part 2 clinical neurology MCQs, and Part 3 clinical OSCE. Note: Part Three is a dedicated practical clinical OSCE; this question bank provides an English-language study aid for lesion localization, diagnostic criteria, and neurological pharmacotherapy across Parts 1 and 2.

Exam sponsor: Egyptian Health Council — Egyptian Board. The requirements and fees below concern the certification or admission exam, separate from our free practice resources.

Assessment

The Egyptian Board in Clinical Neurology (البورد المصري للأمراض العصبية) is administered by the Egyptian Health Council (EHC) under Law No. 12 of 2022 and Prime Ministerial Decree No. 3798 of 2023. Operating as a structured 5-year postgraduate medical training curriculum, the qualification evaluates trainees across three standalone milestones: Part One written examination (held biannually in March and August) covering core neurosciences (neuroanatomy, neurophysiology including EEG and EMG/NCS, neuropathology, and neuropharmacology); Part Two written examination (held biannually in April and September) evaluating comprehensive clinical neurology (stroke, epilepsy, movement disorders, neuroimmunology, neuromuscular diseases, dementia, headache, and neuroinfections); and Part Three clinical exit examination (held in December and January) comprising objective structured clinical examinations (OSCE), clinical neuro-examination stations, EEG/EMG/neuroimaging interpretation, and oral case defenses. Psychometric standard setting is applied using Modified Angoff and Hofstee methods for written parts and Borderline Regression for the clinical OSCE.

Time Limit

Varies by examination part

Passing Score

Set by psychometric standard-setting (Angoff/Hofstee method); no fixed percentage published

Exam / Certification Fees

Determined by Egyptian Health Council decrees per examination part and registration cycle

Exam sponsor website

Reported exam pass rate: Not published by the Egyptian Health Council. Passing standards for written examinations (Part 1 and Part 2) are derived psychometrically using Modified Angoff and Hofstee standard-setting methods, while Part 3 clinical OSCE applies Borderline Regression methodology; fixed numeric pass marks are not released. Exam sponsor website

Fees, eligibility, and exam policies can change. Confirm them with the exam sponsor before applying or paying.

Our practice resources: topics covered

We aim to reflect publicly available exam outlines and topic information in our study resources. Coverage, format, and difficulty may differ from the actual exam, and we cannot guarantee that every detail is accurate or current. Confirm exam requirements, fees, and policies with the official exam sponsor.

15% (Part 1)

Neuroanatomy & Clinical Localization

Brainstem vascular syndromes (Wallenberg, Weber, Millard-Gubler), spinal cord tract anatomy, cranial neuropathies, cortical motor/sensory homunculus, and cerebral arterial territories.

10% (Part 1)

Neurophysiology, EEG & Electromyography

Electroencephalographic rhythms, status epilepticus patterns, nerve conduction studies, F-wave and H-reflex physiology, and repetitive nerve stimulation findings.

10% (Part 1)

Neuropathology & Neuropharmacology

Histopathological hallmarks of neurodegenerative diseases, molecular pathology of demyelination, antiepileptic pharmacodynamics, dopaminergic mechanisms, and immune therapies.

15% (Part 2)

Cerebrovascular Diseases & Acute Stroke

Acute ischemic stroke reperfusion guidelines (IV alteplase/tenecteplase), endovascular thrombectomy time windows (DAWN/DEFUSE-3), ICH blood pressure management, and aneurysmal SAH.

12% (Part 2)

Epilepsy & Seizure Syndromes

ILAE classification of seizures and epilepsies, electroclinical syndromes, refractory status epilepticus treatment algorithms, and antiepileptic selection in pregnancy.

10% (Part 2)

Multiple Sclerosis & Demyelinating Disorders

McDonald diagnostic criteria (dissemination in space and time), CSF oligoclonal bands, NMOSD vs MOGAD differentiation, and disease-modifying therapy risk monitoring.

8% (Part 2)

Movement Disorders

Parkinson disease diagnosis and motor complications, atypical parkinsonism (PSP, MSA, CBD, DLB), hyperkinetic movement disorders, dystonias, and Wilson disease.

8% (Part 2)

Neuromuscular & Motor Neuron Diseases

Myasthenia gravis antibody profiles and crisis management, Lambert-Eaton myasthenic syndrome, Guillain-Barré syndrome variants, CIDP, and Amyotrophic Lateral Sclerosis.

6% (Part 2)

Dementia & Cognitive Disorders

Alzheimer disease core biomarkers, behavioral-variant frontotemporal dementia, dementia with Lewy bodies, normal pressure hydrocephalus, and rapidly progressive dementias.

6% (Part 2)

Headache Syndromes & CNS Infections

Primary headache disorders (migraine, cluster, trigeminal autonomic cephalalgias), secondary headaches, acute bacterial meningitis, viral encephalitis, and neurotuberculosis.

Preparing for the Egyptian Board Neurology Exam

What You Need to Know

  • Passing score: Set by psychometric standard-setting (Angoff/Hofstee method); no fixed percentage published
  • Assessment: The Egyptian Board in Clinical Neurology (البورد المصري للأمراض العصبية) is administered by the Egyptian Health Council (EHC) under Law No. 12 of 2022 and Prime Ministerial Decree No. 3798 of 2023. Operating as a structured 5-year postgraduate medical training curriculum, the qualification evaluates trainees across three standalone milestones: Part One written examination (held biannually in March and August) covering core neurosciences (neuroanatomy, neurophysiology including EEG and EMG/NCS, neuropathology, and neuropharmacology); Part Two written examination (held biannually in April and September) evaluating comprehensive clinical neurology (stroke, epilepsy, movement disorders, neuroimmunology, neuromuscular diseases, dementia, headache, and neuroinfections); and Part Three clinical exit examination (held in December and January) comprising objective structured clinical examinations (OSCE), clinical neuro-examination stations, EEG/EMG/neuroimaging interpretation, and oral case defenses. Psychometric standard setting is applied using Modified Angoff and Hofstee methods for written parts and Borderline Regression for the clinical OSCE.
  • Time limit: Varies by examination part
  • Exam / certification fees: Determined by Egyptian Health Council decrees per examination part and registration cycle Official sources

Using Our Practice Resources

  • Work through all 100 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

Egyptian Board Neurology: Suggested Study Strategy

1Master anatomical localization principles: correlate brainstem cross-sections (midbrain, pons, medulla) and spinal cord cord lesions with specific clinical deficit syndromes.
2Review clinical electrophysiology deeply: understand the criteria for demyelinating versus axonal neuropathy on nerve conduction studies, repetitive nerve stimulation decrements in myasthenia gravis, and characteristic EEG signatures (e.g., 3 Hz spike-and-wave, triphasic waves, PLEDs/LPDs).
3Stay current with acute stroke reperfusion protocols: memorize intravenous thrombolysis inclusion/exclusion time windows, blood pressure thresholds (<185/110 mmHg pre-thrombolysis), and extended endovascular thrombectomy criteria (DAWN and DEFUSE-3 up to 24 hours).
4Focus on the 2017 McDonald criteria for Multiple Sclerosis: understand dissemination in space (DIS), dissemination in time (DIT), and how cerebrospinal fluid oligoclonal bands substitute for DIT.
5Consolidate pharmacological knowledge: know mechanisms of action, drug interactions, adverse effects, and teratogenic risks of antiepileptic drugs (e.g., levetiracetam vs valproate vs lamotrigine) and disease-modifying therapies for multiple sclerosis.

Frequently Asked Questions

What is the Egyptian Board in Clinical Neurology?

The Egyptian Board in Clinical Neurology (البورد المصري للأمراض العصبية) is the definitive postgraduate medical certification governed by the Egyptian Health Council (EHC) pursuant to Law No. 12 of 2022 and Prime Ministerial Decree No. 3798 of 2023. It represents a standardized 5-year medical residency training program that prepares physicians for independent specialist practice in adult clinical neurology.

What is the examination structure of the Egyptian Board Neurology qualification?

The examination comprises three distinct milestones: Part One written examination (basic medical neurosciences: neuroanatomy, neurophysiology, neuropathology, and neuropharmacology, held in March and August); Part Two written examination (clinical neurology MCQs covering vascular, epileptic, demyelinating, movement, neuromuscular, cognitive, and infective disorders, held in April and September); and Part Three exit examination (clinical OSCE, examination stations, EEG/EMG/neuroimaging interpretation, and oral cases, held in December and January).

How are passing scores established for the Egyptian Board exams?

The Egyptian Health Council employs psychometrically validated standard-setting procedures. Written examinations (Parts 1 and 2) use Modified Angoff and Hofstee standard-setting methods to determine criterion-referenced cut scores based on question difficulty and minimal specialist competence. The Part 3 clinical OSCE applies Borderline Regression standard setting. No fixed numerical percentage is published.

What is tested in Part Three of the Egyptian Board examination?

Part Three is an in-person clinical exit examination consisting of an Objective Structured Clinical Examination (OSCE) with multiple standardized patient stations. Candidates are evaluated on bedside neurological examination techniques, localization skills, live neuroimaging (MRI/CT) and electrophysiological (EEG/EMG) interpretation, and structured oral defenses of complex neurological cases.

Does this question bank include Part Three clinical OSCE stations?

No. Part Three is an interactive clinical OSCE and oral case defense. This question bank is a dedicated English-language multiple-choice study aid specifically engineered to prepare candidates for the written cognitive assessments in Part One (neuroanatomy, electrophysiology, localization) and Part Two (clinical guidelines, acute stroke algorithms, epilepsy syndromes, and neuropharmacology).

What are the eligibility requirements for the Egyptian Board in Clinical Neurology?

Candidates must hold an MBBCh or recognized equivalent primary medical degree, have satisfactorily completed the mandatory medical internship (foundation training), hold an active Egyptian medical practice license, and be formally enrolled in an accredited 5-year clinical neurology residency training post approved by the Egyptian Health Council.

Are these practice questions official EHC examination items?

No. These questions are original educational items authored to reflect the EHC reference curriculum, the Egyptian Board learning outcomes, international neurological clinical guidelines, and standard MCQ item-writing best practices. They serve as an independent study aid for Egyptian Board trainees.